T80.82 - Complication of immune effector cellular therapy
- Applicable to Complication of immune effector cellular therapy
- The 2025 edition of ICD10-CM T80.82 became effective on October 1, 2024.
- This is the American ICD10-CM version of T80.82 - other international versions of ICD10 T80.82 may differ.
- T80.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code Additional Code
- code to identify the specific complication, such as:
- cytokine release syndrome (D89.83-)
- immune effector cell-associated neurotoxicity syndrome (G92.0-)
Inclusion Term
- Complication of chimeric antigen receptor (CAR-T) cell therapy
- Complication of IEC therapy
Type 2 Excludes
- adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
- complication of bone marrow transplant (T86.0)
- complication of stem cell transplant (T86.5)
The following codes above T80.82 contain annotation back-references that may be applicable to T80.82:
Chapter: S00-T88 Injury, poisoning and certain other consequences of external causes
Section: T80-T88 Complications of surgical and medical care, not elsewhere classified
Category: T80 Complications following infusion, transfusion and therapeutic injection
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com